Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial cytoplasmic membrane phospholipids are essential structural components of the bacterial cell envelope, providing a semi-permeable barrier that maintains cellular homeostasis (Epand et al., 2016). Unlike eukaryotic membranes, which are rich in phosphatidylcholine and cholesterol, bacterial membranes are characterized by high concentrations of anionic phospholipids such as phosphatidylglycerol (PG) and cardiolipin (CL) (Sohlenkamp & Geiger, 2016). These lipids serve as the primary target for several classes of antibiotics, most notably the lipopeptide daptomycin, which binds to PG in a calcium-dependent manner to induce membrane curvature and pore formation (Muller et al., 2016). Polymyxins also interact with these phospholipids in the cytoplasmic membrane after crossing the outer membrane of Gram-negative bacteria, leading to physical disruption of the bilayer (Trimble et al., 2016). The interaction typically results in rapid membrane depolarization, leakage of essential ions like potassium, and the cessation of macromolecular synthesis, ultimately leading to cell death (Silverman et al., 2003). Because these targets are fundamental to bacterial viability and differ significantly from human lipid compositions, they remain a critical focus for developing treatments against multi-drug resistant pathogens (Hurdle et al., 2011).
Binding to anionic phospholipids leads to membrane depolarization, pore formation, and loss of membrane integrity, resulting in the leakage of intracellular ions and cell death.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial cytoplasmic membrane phospholipids.